Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Income/(Loss) and Total Comprehensive Income/(Loss) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Income/(Loss) and Total Comprehensive Income/(Loss) (Unaudited) - GBP (£)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Profit or loss [abstract]    
Revenue £ 989,330 £ 989,330
Research and development expenses (3,698,142) (2,907,758)
Administrative expenses (4,077,671) (885,280)
Administrative expenses – costs related to preparing for a listing (1,133,099)
Total operating expenses, net (8,908,912) (3,793,038)
Other income 54,002 5,946
Change in fair value of convertible loan derivatives 6,943,594
Change in fair value of warrants 10,537,611
Change in fair value of other derivative liabilities (3,832,379)
Finance income – interest 4 21
Finance costs (5,990,592) (362,958)
Loss before tax (207,342) (3,160,699)
Income tax credit 720,000 512,507
Net income/(loss) for the period and Total comprehensive income/(loss) £ 512,658 £ (2,648,192)
Basic income/(loss) per share £ 0.93 £ (6.79)
Diluted income/(loss) per share £ 0.76 £ (6.79)